Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANE SHEETS

v3.20.1
CONDENSED CONSOLIDATED BALANE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 34,530 $ 85,452
Accounts receivable, net 132,476 134,617
Inventory, net 58,697 53,434
Other current assets and prepaid expenses 48,754 50,542
Total current assets 274,457 324,045
Property, plant and equipment, net 127,304 127,111
Intangible assets, net 513,511 528,962
In-process research and development 590,200 590,200
Goodwill 669,582 671,940
Investments 10,669 20,746
Operating lease right-of-use assets 39,793 39,380
Other assets 7,026 6,888
Total assets 2,232,542 2,309,272
Current liabilities:    
Accounts payable 55,866 62,537
Accrued expenses 164,939 164,925
Current maturities of operating leases 11,480 12,038
Current portion of lines of credit and notes payable 12,802 9,619
Total current liabilities 245,087 249,119
Operating lease liabilities 28,669 27,665
Convertible notes 213,805 211,208
Deferred tax liabilities, net 118,600 118,717
Other long-term liabilities, principally contract liabilities, contingent consideration and line of credit 77,762 87,804
Total long-term liabilities 438,836 445,394
Total liabilities 683,923 694,513
Equity:    
Common Stock - $0.01 par value, 1,000,000,000 shares authorized; 670,378,701 and 670,378,701 shares issued at March 31, 2020 and December 31, 2019, respectively 6,704 6,704
Treasury Stock - 549,907 shares at March 31, 2020 and December 31, 2019, respectively (1,791) (1,791)
Additional paid-in capital 3,145,444 3,142,993
Accumulated other comprehensive loss (30,187) (22,070)
Accumulated deficit (1,571,551) (1,511,077)
Total shareholders’ equity 1,548,619 1,614,759
Total liabilities and equity $ 2,232,542 $ 2,309,272